{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:15:29Z","timestamp":1792181729277,"version":"4.4.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.iac.2024.03.004","type":"journal-article","created":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T04:10:31Z","timestamp":1716005431000},"page":"453-467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Chronic Spontaneous Urticaria"],"prefix":"10.1016","volume":"44","author":[{"given":"Levi","family":"Keller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Stitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.iac.2024.03.004_bib1","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1056\/NEJMra2120166","article-title":"Chronic Urticaria","volume":"387","author":"Lang","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.iac.2024.03.004_bib2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2133.2008.08920.x","article-title":"Chronic urticaria: an internet survey of health behaviours, symptom patterns and treatment needs in European adult patients","volume":"160","author":"Maurer","year":"2009","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.iac.2024.03.004_bib3","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/all.15090","article-title":"The international EAACI\/GA2LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria","volume":"77","author":"Zuberbier","year":"2022","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.iac.2024.03.004_bib4","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/jama.1994.03520080061045","article-title":"A\u00a0Critical-Appraisal of the Quality of Quality-of-Life Measurements","volume":"272","author":"Gill","year":"1994","journal-title":"JAMA, J Am Med Assoc"},{"issue":"26","key":"10.1016\/j.iac.2024.03.004_bib5","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJM198606263142602","article-title":"The effects of antihypertensive therapy on the quality of life","volume":"314","author":"Croog","year":"1986","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.iac.2024.03.004_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/bjc.1988.20","article-title":"Who should measure quality of life, the doctor or the patient?","volume":"57","author":"Slevin","year":"1988","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.iac.2024.03.004_bib7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1398-9995.2008.01853.x","article-title":"Chronic urticaria: a patient survey on quality-of-life, treatment usage and doctor-patient relation","volume":"64","author":"Maurer","year":"2009","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.iac.2024.03.004_bib8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1398-9995.2009.02263.x","article-title":"Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper","volume":"65","author":"Baiardini","year":"2010","journal-title":"Allergy"},{"issue":"Suppl 2","key":"10.1016\/j.iac.2024.03.004_bib9","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1111\/j.1524-4733.2007.00275.x","article-title":"Patient-reported outcomes to support medical product labeling claims: FDA perspective","volume":"10","author":"Patrick","year":"2007","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.iac.2024.03.004_bib10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4104\/pcrj.2012.00084","article-title":"Systematic literature review and evaluation of patient reported outcome measures (PROMs) for asthma and related allergic diseases","volume":"21","author":"Worth","year":"2012","journal-title":"Prim Care Respir J"},{"issue":"7","key":"10.1016\/j.iac.2024.03.004_bib11","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1398-9995.2011.02580.x","article-title":"Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper","volume":"66","author":"Baiardini","year":"2011","journal-title":"Allergy"},{"issue":"12","key":"10.1016\/j.iac.2024.03.004_bib12","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1038\/sj.jid.5701142","article-title":"Critical review of generic and dermatology-specific health-related quality of life instruments","volume":"127","author":"Both","year":"2007","journal-title":"J\u00a0Invest Dermatol"},{"issue":"3","key":"10.1016\/j.iac.2024.03.004_bib13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Indec (DLQI) - a simple practical measure for routine clinical use","volume":"19","author":"Finlay AY","year":"1994","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"10.1016\/j.iac.2024.03.004_bib14","first-page":"997","article-title":"The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results","volume":"159","author":"Basra","year":"2008","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.iac.2024.03.004_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1046\/j.1365-2133.2003.05158.x","article-title":"Dermatology Life Quality Index: Influence of an illustrated version","volume":"148","author":"Loo","year":"2003","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.iac.2024.03.004_bib16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.0022-202X.2005.23621.x","article-title":"Translating the science of quality of life into practice: What do dermatology life quality index scores mean?","volume":"125","author":"Hongbo","year":"2005","journal-title":"J\u00a0Invest Dermatol"},{"issue":"1","key":"10.1016\/j.iac.2024.03.004_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1385\/CRIAI:30:1:047","article-title":"Urticaria and quality of life","volume":"30","author":"Grob","year":"2006","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"10.1016\/j.iac.2024.03.004_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1365-2133.1997.d01-1168.x","article-title":"The impact of chronic urticaria on the quality of life","volume":"136","author":"O'Donnell","year":"1997","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.iac.2024.03.004_bib19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/jech.34.4.281","article-title":"A\u00a0quantitative approach to perceived health status: a validation study","volume":"34","author":"Hunt","year":"1980","journal-title":"J\u00a0Epidemiol Community Health"},{"issue":"4","key":"10.1016\/j.iac.2024.03.004_bib20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/jech.35.4.297","article-title":"Reliability of a population survey tool for measuring perceived health problems: a study of patients with osteoarthrosis","volume":"35","author":"Hunt","year":"1981","journal-title":"J\u00a0Epidemiol Community Health"},{"issue":"6775","key":"10.1016\/j.iac.2024.03.004_bib21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/bmj.302.6775.511","article-title":"Prospective study of quality of life before and after coronary artery bypass grafting","volume":"302","author":"Caine","year":"1991","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.iac.2024.03.004_bib22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2133.2005.06385.x","article-title":"Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life","volume":"152","author":"Grob","year":"2005","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.iac.2024.03.004_bib23","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1398-9995.2005.00833.x","article-title":"A\u00a0new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL)","volume":"60","author":"Baiardini","year":"2005","journal-title":"Allergy"},{"issue":"10","key":"10.1016\/j.iac.2024.03.004_bib24","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1001\/archdermatol.2011.310","article-title":"Chronic spontaneous urticaria: how to assess quality of life in patients receiving treatment","volume":"147","author":"Weller","year":"2011","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.iac.2024.03.004_bib25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2133.1997.tb14934.x","article-title":"Quality of life measurement in dermatology: a practical guide","volume":"136","author":"Finlay","year":"1997","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.iac.2024.03.004_bib26","first-page":"426","article-title":"Adaptation and validation of the Spanish version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL)","volume":"18","author":"Valero","year":"2008","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2024.03.004_bib27","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2340\/00015555-1199","article-title":"Turkish version of the chronic urticaria quality of life questionnaire: cultural adaptation, assessment of reliability and validity","volume":"92","author":"Kocaturk","year":"2012","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.iac.2024.03.004_bib28","first-page":"36","article-title":"Adaptation and initial results of the Polish version of the GA(2)LEN chronic urticaria quality of life questionnaire (CU-Q(2)oL)","volume":"62","author":"Brzoza","year":"2011","journal-title":"J\u00a0Dermatol Sci"},{"issue":"11","key":"10.1016\/j.iac.2024.03.004_bib29","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/j.1398-9995.2011.02695.x","article-title":"Cross-cultural adaptation of the Brazilian-Portuguese version of the chronic urticaria quality-of-life questionnaire - CU-Q2oL","volume":"66","author":"Dias","year":"2011","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.iac.2024.03.004_bib30","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/j.1398-9995.2008.01920.x","article-title":"The German version of the Chronic Urticaria Quality-of-Life Questionnaire: factor analysis, validation, and initial clinical findings","volume":"64","author":"Mlynek","year":"2009","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.iac.2024.03.004_bib31","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jaip.2017.06.023","article-title":"Chronic Urticaria Patient Perspective (CUPP): The First Validated Tool for Assessing Quality of Life in Clinical Practice","volume":"6","author":"Baiardini","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"6304","key":"10.1016\/j.iac.2024.03.004_bib32","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1136\/bmj.283.6304.1435-a","article-title":"Antihistamine treatment: a patient self-assessment method in chronic urticaria","volume":"283","author":"Greaves","year":"1981","journal-title":"Br Med J"},{"issue":"6","key":"10.1016\/j.iac.2024.03.004_bib33","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1398-9995.2008.01726.x","article-title":"How to assess disease activity in patients with chronic urticaria?","volume":"63","author":"Mlynek","year":"2008","journal-title":"Allergy"},{"issue":"10","key":"10.1016\/j.iac.2024.03.004_bib34","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa1215372","article-title":"Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria","volume":"368","author":"Maurer","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.iac.2024.03.004_bib35","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/jid.2014.512","article-title":"Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic\/Spontaneous Urticaria who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study","volume":"135","author":"Saini","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.iac.2024.03.004_bib36","article-title":"Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials","volume":"S0091","author":"Maurer","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2024.03.004_bib37","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jaci.2023.10.007","article-title":"Remibrutinib demonstrates favorable safety profile and sustained efficacy in chronic spontaneous urticaria over 52 weeks","volume":"153","author":"Jain","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2024.03.004_bib38","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jaci.2013.12.1076","article-title":"Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control","volume":"133","author":"Weller","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.iac.2024.03.004_bib39","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/all.13397","article-title":"The EAACI\/GA(2)LEN\/EDF\/WAO guideline for the definition, classification, diagnosis and management of urticaria","volume":"73","author":"Zuberbier","year":"2018","journal-title":"Allergy"},{"issue":"12","key":"10.1016\/j.iac.2024.03.004_bib40","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1016\/j.jaip.2022.07.037","article-title":"Validation of the Urticaria Control Test (UCT) in Children With Chronic Urticaria","volume":"10","author":"Prosty","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.iac.2024.03.004_bib41","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.anai.2018.03.012","article-title":"Validity and responsiveness of the Urticaria Activity and Impact Measure: A new patient-reported tool","volume":"120","author":"Maurer","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.iac.2024.03.004_bib42","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1046\/j.1365-2133.1999.02767.x","article-title":"The extent and nature of disability in different urticarial conditions","volume":"140","author":"Poon","year":"1999","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.iac.2024.03.004_bib43","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/all.12209","article-title":"Development, validation, and initial results of the Angioedema Activity Score","volume":"68","author":"Weller","year":"2013","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.iac.2024.03.004_bib44","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/all.14144","article-title":"Development of the Angioedema Control Test-A patient-reported outcome measure that assesses disease control in patients with recurrent angioedema","volume":"75","author":"Weller","year":"2020","journal-title":"Allergy"},{"issue":"10","key":"10.1016\/j.iac.2024.03.004_bib45","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/all.12007","article-title":"Development and construct validation of the angioedema quality of life questionnaire","volume":"67","author":"Weller","year":"2012","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.iac.2024.03.004_bib46","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/all.12900","article-title":"The Angioedema Quality of Life Questionnaire (AE-QoL) - assessment of sensitivity to change and minimal clinically important difference","volume":"71","author":"Weller","year":"2016","journal-title":"Allergy"},{"issue":"9","key":"10.1016\/j.iac.2024.03.004_bib47","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1468-3083.2008.02714.x","article-title":"Relationship between anger and pruritus perception in patients with chronic idiopathic urticaria and psoriasis","volume":"22","author":"Conrad","year":"2008","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.iac.2024.03.004_bib48","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/13548506.2010.525657","article-title":"Alexithymia in chronic urticaria patients","volume":"16","author":"Barbosa","year":"2011","journal-title":"Psychol Health Med"},{"issue":"1","key":"10.1016\/j.iac.2024.03.004_bib49","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00006842-199401000-00005","article-title":"Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria","volume":"56","author":"Gupta","year":"1994","journal-title":"Psychosom Med"},{"issue":"1","key":"10.1016\/j.iac.2024.03.004_bib50","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1365-2133.2002.04758.x","article-title":"Clinical characteristics of pruritus in chronic idiopathic urticaria","volume":"147","author":"Yosipovitch","year":"2002","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.iac.2024.03.004_bib51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1081-1206(10)60617-5","article-title":"Psychiatric morbidity and quality of life in patients with chronic idiopathic urticaria","volume":"99","author":"\u00d6zkan","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.iac.2024.03.004_bib52","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1398-9995.2010.02496.x","article-title":"Unmet clinical needs in chronic spontaneous urticaria. A GA(2)LEN task force report","volume":"66","author":"Maurer","year":"2011","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.iac.2024.03.004_bib53","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/all.12068","article-title":"Psychosocial factors and chronic spontaneous urticaria: a systematic review","volume":"68","author":"Ben-Shoshan","year":"2013","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.iac.2024.03.004_bib54","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2222.2007.02864.x","article-title":"Effect of stress on basophil function in chronic idiopathic urticaria","volume":"38","author":"Dyke","year":"2008","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"10.1016\/j.iac.2024.03.004_bib55","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/PSY.0b013e31817bcc8d","article-title":"Decline in dehydroepiandrosterone sulfate observed in chronic urticaria is associated with psychological distress","volume":"70","author":"Brzoza","year":"2008","journal-title":"Psychosom Med"},{"issue":"5","key":"10.1016\/j.iac.2024.03.004_bib56","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1046\/j.1365-2133.2000.03831.x","article-title":"Psychiatric morbidity in dermatological outpatients: an issue to be recognized","volume":"143","author":"Picardi","year":"2000","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.iac.2024.03.004_bib57","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/archpsyc.1988.01800350011002","article-title":"One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites","volume":"45","author":"Regier","year":"1988","journal-title":"Arch Gen Psychiatr"},{"key":"10.1016\/j.iac.2024.03.004_bib58","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13601-019-0278-3","article-title":"Psychiatric comorbidity in chronic urticaria patients: a systematic review and meta-analysis","volume":"9","author":"Konstantinou","year":"2019","journal-title":"Clin Transl Allergy"},{"issue":"2","key":"10.1016\/j.iac.2024.03.004_bib59","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jpsychores.2007.08.006","article-title":"Axis I and Axis II diagnoses in patients with chronic idiopathic urticaria","volume":"64","author":"Uguz","year":"2008","journal-title":"J\u00a0Psychosom Res"},{"issue":"5","key":"10.1016\/j.iac.2024.03.004_bib60","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.genhosppsych.2008.06.006","article-title":"Quality of life in patients with chronic idiopathic urticaria: the impact of Axis I and Axis II psychiatric disorders","volume":"30","author":"Uguz","year":"2008","journal-title":"Gen Hosp Psychiatr"},{"issue":"2","key":"10.1016\/j.iac.2024.03.004_bib61","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1365-2133.2005.06976.x","article-title":"Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity","volume":"154","author":"Staubach","year":"2006","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.iac.2024.03.004_bib62","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1468-3083.2007.02324.x","article-title":"The levels of depression, anxiety and quality of life in patients with chronic idiopathic urticaria","volume":"22","author":"Engin","year":"2008","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.iac.2024.03.004_bib63","first-page":"149","article-title":"Chronic urticaria: importance of a medical-psychological approach","volume":"38","author":"Berrino","year":"2006","journal-title":"Eur Ann Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2024.03.004_bib64","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/j.1365-2133.2010.10138.x","article-title":"Levels of depression, anxiety and behavioural problems and frequency of psychiatric disorders in children with chronic idiopathic urticaria","volume":"164","author":"Herguner","year":"2011","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.iac.2024.03.004_bib65","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/archdermatol.2007.5","article-title":"Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients","volume":"144","author":"Delong","year":"2008","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.iac.2024.03.004_bib66","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/bjd.19561","article-title":"The global burden of chronic urticaria for the patient and society","volume":"184","author":"Goncalo","year":"2021","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.iac.2024.03.004_bib67","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.jaip.2019.11.004","article-title":"Optimizing Value in the Evaluation of Chronic Spontaneous Urticaria: A Cost-Effectiveness Analysis","volume":"8","author":"Shaker","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.iac.2024.03.004_bib68","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s40257-015-0134-8","article-title":"Resource use and costs in an insured population of patients with chronic idiopathic\/spontaneous urticaria","volume":"16","author":"Broder","year":"2015","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"10.1016\/j.iac.2024.03.004_bib69","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/bjd.16476","article-title":"Cost-effectiveness of omalizumab for the treatment of chronic spontaneous urticaria","volume":"179","author":"Kanters","year":"2018","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.iac.2024.03.004_bib70","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.anai.2011.10.018","article-title":"Cost, utilization, and patterns of medication use associated with chronic idiopathic urticaria","volume":"108","author":"Zazzali","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.iac.2024.03.004_bib71","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1001\/archdermatol.2007.6","article-title":"Chronic idiopathic urticaria: a \"Cinderella\" disease with a negative impact on quality of life and health care costs","volume":"144","author":"Yosipovitch","year":"2008","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.iac.2024.03.004_bib72","first-page":"341","article-title":"Cost-intensive, time-consuming, problematical? How physicians in private practice experience the care of urticaria patients","volume":"10","author":"Weller","year":"2012","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"issue":"3","key":"10.1016\/j.iac.2024.03.004_bib73","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jaad.2006.05.048","article-title":"The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology","volume":"55","author":"Bickers","year":"2006","journal-title":"J\u00a0Am Acad Dermatol"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856124000262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856124000262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T22:19:50Z","timestamp":1719353990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856124000262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0889856124000262"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2024.03.004","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic Spontaneous Urticaria","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2024.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}